Channelpedia

Kv7.2 Channel

512 automatically matched literature references

2

Dai G et al. Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels.
Proc. Natl. Acad. Sci. U.S.A., 2016 Jun 7 , 113 (E3290-9).

3

Kumar M et al. Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators.
Mol. Pharmacol., 2016 Jun , 89 (667-77).

4

Schütze S et al. KCNQ Potassium Channels Modulate Sensitivity of Skin D-hair Mechanoreceptors.
J. Biol. Chem., 2016 Jan 5 , ().

11

12

Reid ES et al. Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6.
JIMD Rep, 2015 Oct 8 , ().

14

Santella L et al. Assisted yes, but where do we draw the line?
Reprod. Biomed. Online, 2015 Oct , 31 (476-8).

15

Barrese V et al. Protective role of Kv7 channels in oxygen and glucose deprivation-induced damage in rat caudate brain slices.
J. Cereb. Blood Flow Metab., 2015 Oct , 35 (1593-600).

16

Milh M et al. Variable clinical expression in patients with mosaicism for KCNQ2 mutations.
Am. J. Med. Genet. A, 2015 Oct , 167A (2314-8).

17

Davoren JE et al. Discovery of a novel Kv7 channel opener as a treatment for epilepsy.
Bioorg. Med. Chem. Lett., 2015 Nov 1 , 25 (4941-4).

18

Pisano T et al. Early and effective treatment of KCNQ2 encephalopathy.
Epilepsia, 2015 May , 56 (685-91).

19

Mercimek-Mahmutoglu S et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Epilepsia, 2015 May , 56 (707-16).

20

Pribaz E et al. The Jack Pribaz Foundation and KCNQ2.org.
Epilepsia, 2015 May , 56 (682-4).

21

Kaminsky Z et al. DNA methylation and expression of KCNQ3 in bipolar disorder.
Bipolar Disord, 2015 Mar , 17 (150-9).

23

Okumura A et al. Phenotypes of children with 20q13.3 microdeletion affecting KCNQ2 and CHRNA4.
Epileptic Disord, 2015 Jun , 17 (165-71).

30

Boutry-Kryza N et al. Molecular characterization of a cohort of 73 patients with infantile spasms syndrome.
Eur J Med Genet, 2015 Feb , 58 (51-8).

31

Hashimoto R et al. Uncompacted Myelin Lamellae and Nodal Ion Channel Disruption in POEMS Syndrome.
J. Neuropathol. Exp. Neurol., 2015 Dec , 74 (1127-36).

34

Gomis-Perez C et al. An unconventional calmodulin-anchoring site within the AB module of Kv7.2 channels.
J. Cell. Sci., 2015 Aug 15 , 128 (3155-63).

37

Figueiro-Silva J et al. Neuronal pentraxin 1 negatively regulates excitatory synapse density and synaptic plasticity.
J. Neurosci., 2015 Apr 8 , 35 (5504-21).

40

42

Zhang F et al. Inhibition of Kv7/M Channel Currents by the Local Anesthetic Chloroprocaine.
Pharmacology, 2015 , 96 (124-30).

43

Shimatani Y et al. Abnormal gating of axonal slow potassium current in cramp-fasciculation syndrome.
Clin Neurophysiol, 2014 Sep 28 , ().

44

Cuppoletti J et al. Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents.
Am. J. Physiol., Cell Physiol., 2014 Sep 1 , 307 (C479-92).

45

Allen NM et al. The variable phenotypes of KCNQ-related epilepsy.
Epilepsia, 2014 Sep , 55 (e99-105).

46

Zerem A et al. Paternal germline mosaicism of a SCN2A mutation results in Ohtahara syndrome in half siblings.
Eur. J. Paediatr. Neurol., 2014 Sep , 18 (567-71).

47

Grigorov A et al. Kv7 potassium channel subunits and M currents in cultured hippocampal interneurons.
Pflugers Arch., 2014 Sep , 466 (1747-58).

48

King CH et al. Kv7.2 regulates the function of peripheral sensory neurons.
J. Comp. Neurol., 2014 Oct 1 , 522 (3262-80).

50

Frolov RV et al. Celecoxib and ion channels: a story of unexpected discoveries.
Eur. J. Pharmacol., 2014 May 5 , 730 (61-71).

52

Brueggemann LI et al. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
Am. J. Physiol. Lung Cell Mol. Physiol., 2014 Mar 15 , 306 (L476-86).

55

Jepps TA et al. Vasorelaxant effects of novel Kv7.4 channel enhancers ML213 and NS15370.
Br. J. Pharmacol., 2014 Jun 9 , ().

61

Gourgy-Hacohen O et al. Capturing distinct KCNQ2 channel resting states by metal ion bridges in the voltage-sensor domain.
J. Gen. Physiol., 2014 Dec , 144 (513-27).

62

Li P et al. The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.
J. Pharmacol. Exp. Ther., 2014 Dec , 351 (596-604).

65

Moreau A et al. Biophysics, pathophysiology, and pharmacology of ion channel gating pores.
Front Pharmacol, 2014 , 5 (53).

66

Hille B et al. Dynamic metabolic control of an ion channel.
Prog Mol Biol Transl Sci, 2014 , 123 (219-47).

67

Dalen Meurs-van der Schoor C et al. Severe Neonatal Epileptic Encephalopathy and KCNQ2 Mutation: Neuropathological Substrate?
Front Pediatr, 2014 , 2 (136).

68

Tomonoh Y et al. The kick-in system: a novel rapid knock-in strategy.
PLoS ONE, 2014 , 9 (e88549).

72

Maljevic S et al. Potassium channel genes and benign familial neonatal epilepsy.
Prog. Brain Res., 2014 , 213 (17-53).

73

Soh H et al. Cortical KCNQ2/3 channels; insights from knockout mice.
Channels (Austin), 2014 , 8 (389-90).

74

Kole MH et al. Axonal Kv7.2/7.3 channels: caught in the act.
Channels (Austin), 2014 , 8 (288-9).

77

[To the mechanisms of antiarrhythmic action of Allapinine].
Bioorg. Khim., 2013 Jan-Feb , 39 (105-16).

78

Svalø J et al. Bladder contractility is modulated by Kv7 channels in pig detrusor.
Eur. J. Pharmacol., 2013 Sep 5 , 715 (312-20).

79

Kornilov P et al. Channel gating pore: a new therapeutic target.
Cell Res., 2013 Sep , 23 (1067-8).

81

Reilly JM et al. Kv7/M-type potassium channels in rat skin keratinocytes.
Pflugers Arch., 2013 Sep , 465 (1371-81).

82

Vetter I et al. Amplified cold transduction in native nociceptors by M-channel inhibition.
J. Neurosci., 2013 Oct 16 , 33 (16627-41).

83

Salyer SA et al. Vacuolar ATPase driven potassium transport in highly metastatic breast cancer cells.
Biochim. Biophys. Acta, 2013 Oct , 1832 (1734-43).

84

Hu HN et al. Discovery of a retigabine derivative that inhibits KCNQ2 potassium channels.
Acta Pharmacol. Sin., 2013 Oct , 34 (1359-66).

86

88

90

91

Fister P et al. Benign familial neonatal convulsions caused by mutation in KCNQ3, exon 6: a European case.
Eur. J. Paediatr. Neurol., 2013 May , 17 (308-10).

93

97

100

Li S et al. Pathogenic plasticity of Kv7.2/3 channel activity is essential for the induction of tinnitus.
Proc. Natl. Acad. Sci. U.S.A., 2013 Jun 11 , 110 (9980-5).

105

106

Alaimo A et al. Cooperativity between calmodulin-binding sites in Kv7.2 channels.
J. Cell. Sci., 2013 Jan 1 , 126 (244-53).

107

Saadeldin IY et al. Novel KCNQ2 mutation in a large Emirati family with benign familial neonatal seizures.
Pediatr. Neurol., 2013 Jan , 48 (63-6).

111

Zhang Q et al. Dynamic PIP2 interactions with voltage sensor elements contribute to KCNQ2 channel gating.
Proc. Natl. Acad. Sci. U.S.A., 2013 Dec 10 , 110 (20093-8).

112

Khanamiri S et al. Contribution of Kv7 channels to basal coronary flow and active response to ischemia.
Hypertension, 2013 Dec , 62 (1090-7).

113

Lee YH et al. Pathway analysis of a genome-wide association study in schizophrenia.
Gene, 2013 Aug 1 , 525 (107-15).

115

Lichter-Peled A et al. Role of KCNQ2 and KCNQ3 genes in juvenile idiopathic epilepsy in Arabian foals.
Vet. J., 2013 Apr , 196 (57-63).

118

Glasgow SD et al. Muscarinic depolarization of layer II neurons of the parasubiculum.
PLoS ONE, 2013 , 8 (e58901).

119

Bennett V et al. Spectrin- and ankyrin-based membrane domains and the evolution of vertebrates.
Curr Top Membr, 2013 , 72 (1-37).

121

Cavaliere S et al. KCNQ channels regulate age-related memory impairment.
PLoS ONE, 2013 , 8 (e62445).

123

Robbins J et al. Effects of KCNQ2 gene truncation on M-type Kv7 potassium currents.
PLoS ONE, 2013 , 8 (e71809).

124

Dai X et al. Effects of estrogen on neuronal KCNQ2/3 channels expressed in PC-12 cells.
Biol. Pharm. Bull., 2013 , 36 (1583-6).

126

Ferrer T et al. Tamoxifen inhibition of kv7.2/kv7.3 channels.
PLoS ONE, 2013 , 8 (e76085).

130

133

136

Pattnaik BR et al. Effects of KCNQ channel modulators on the M-type potassium current in primate retinal pigment epithelium.
Am. J. Physiol., Cell Physiol., 2012 Mar , 302 (C821-33).

137

Choveau FS et al. Pore helix-S6 interactions are critical in governing current amplitudes of KCNQ3 K+ channels.
Biophys. J., 2012 Jun 6 , 102 (2499-509).

138

Choveau FS et al. Pore determinants of KCNQ3 K+ current expression.
Biophys. J., 2012 Jun 6 , 102 (2489-98).

140

King CH et al. Kv7.5 is the primary Kv7 subunit expressed in C-fibers.
J. Comp. Neurol., 2012 Jun 15 , 520 (1940-50).

143

Telezhkin V et al. Distinct subunit contributions to the activation of M-type potassium channels by PI(4,5)P2.
J. Gen. Physiol., 2012 Jul , 140 (41-53).

147

Weckhuysen S et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.
Ann. Neurol., 2012 Jan , 71 (15-25).

148

Kamoun FF et al. Frontal motor seizure following non-convulsive status epilepticus in ring chromosome 20 syndrome.
Neurosciences (Riyadh), 2012 Jan , 17 (74-7).

150

Linley JE et al. M channel enhancers and physiological M channel block.
J. Physiol. (Lond.), 2012 Feb 15 , 590 (793-807).

152

Chege SW et al. Expression and function of KCNQ channels in larval zebrafish.
Dev Neurobiol, 2012 Feb , 72 (186-98).

154

Mefford HC et al. Epilepsy due to 20q13.33 subtelomere deletion masquerading as pyridoxine-dependent epilepsy.
Am. J. Med. Genet. A, 2012 Dec , 158A (3190-5).

156

Idevall-Hagren O et al. Optogenetic control of phosphoinositide metabolism.
Proc. Natl. Acad. Sci. U.S.A., 2012 Aug 28 , 109 (E2316-23).

157

Bocksteins E et al. Kv3 channels contribute to the delayed rectifier current in small cultured mouse dorsal root ganglion neurons.
Am. J. Physiol., Cell Physiol., 2012 Aug 15 , 303 (C406-15).

158

Saitsu H et al. Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome.
Ann. Neurol., 2012 Aug , 72 (298-300).

159

Stewart AP et al. The Kv7.2/Kv7.3 heterotetramer assembles with a random subunit arrangement.
J. Biol. Chem., 2012 Apr 6 , 287 (11870-7).

162

163

Yoshimura S et al. Genetic and infectious profiles of Japanese multiple sclerosis patients.
PLoS ONE, 2012 , 7 (e48592).

167

Klinger F et al. Distribution of M-channel subunits KCNQ2 and KCNQ3 in rat hippocampus.
Neuroimage, 2011 Oct 1 , 58 (761-9).

170

Jensen MM et al. The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.
Basic Clin. Pharmacol. Toxicol., 2011 Nov , 109 (339-42).

173

Zhang J et al. AKAP79/150 Signal Complexes in G-Protein Modulation of Neuronal Ion Channels.
J. Neurosci., 2011 May 11 , 31 (7199-211).

174

Mulley JC et al. Epilepsy and the new cytogenetics.
Epilepsia, 2011 Mar , 52 (423-32).

176

Zhou X et al. Novel role of KCNQ2/3 channels in regulating neuronal cell viability.
Cell Death Differ., 2011 Mar , 18 (493-505).

178

Kristensen LV et al. Kv7 (KCNQ) channel openers induce hypothermia in the mouse.
Neurosci. Lett., 2011 Jan 20 , 488 (178-82).

180

Zhang D et al. KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.
J. Neurosci. Methods, 2011 Aug 30 , 200 (54-62).

181

Jepps TA et al. Downregulation of Kv7.4 channel activity in primary and secondary hypertension.
Circulation, 2011 Aug 2 , 124 (602-11).

182

Roepke TA et al. Fasting and 17β-estradiol differentially modulate the M-current in neuropeptide Y neurons.
J. Neurosci., 2011 Aug 17 , 31 (11825-35).

183

185

Zhou XH et al. [Site-directed mutagenesis and protein expression of KCNQ2 gene associated with neonatal convulsions].
Zhongguo Dang Dai Er Ke Za Zhi, 2011 Aug , 13 (611-6).

192

Gómez-Posada JC et al. Kv7 channels can function without constitutive calmodulin tethering.
PLoS ONE, 2011 , 6 (e25508).

198

Zhong XZ et al. Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.
J. Physiol. (Lond.), 2010 Sep 1 , 588 (3277-93).

200

202

Lötsch J et al. Pharmacogenetics of new analgesics.
, 2010 Oct 13 , ().

205

Tzingounis AV et al. The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus.
Proc. Natl. Acad. Sci. U.S.A., 2010 Jun 1 , 107 (10232-7).

206

Meisler MH et al. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects.
J. Physiol. (Lond.), 2010 Jun 1 , 588 (1841-8).

207

Gómez-Posada JC et al. A pore residue of the KCNQ3 potassium M-channel subunit controls surface expression.
J. Neurosci., 2010 Jul 7 , 30 (9316-23).

208

Fritch PC et al. Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.
J. Med. Chem., 2010 Jan 28 , 53 (887-96).

209

Hoshi N et al. Interaction with AKAP79 modifies the cellular pharmacology of PKC.
Mol. Cell, 2010 Feb 26 , 37 (541-50).

210

Bal M et al. Ca2+/calmodulin disrupts AKAP79/150 interactions with KCNQ (M-Type) K+ channels.
J. Neurosci., 2010 Feb 10 , 30 (2311-23).

212

Falkenburger BH et al. Kinetics of M1 muscarinic receptor and G protein signaling to phospholipase C in living cells.
J. Gen. Physiol., 2010 Feb , 135 (81-97).

213

215

Baulac S et al. Advances on the genetics of mendelian idiopathic epilepsies.
Clin. Lab. Med., 2010 Dec , 30 (911-29).

217

Peretz A et al. Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier.
Proc. Natl. Acad. Sci. U.S.A., 2010 Aug 31 , 107 (15637-42).

219

Kotzamanis G et al. CFTR expression from a BAC carrying the complete human gene and associated regulatory elements.
J. Cell. Mol. Med., 2009 Sep , 13 (2938-48).

220

222

223

Padilla K et al. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
Neurosci. Lett., 2009 Nov 13 , 465 (138-42).

224

Goldberg-Stern H et al. Novel mutation in KCNQ2 causing benign familial neonatal seizures.
Pediatr. Neurol., 2009 Nov , 41 (367-70).

225

Baulac S et al. Advances on the genetics of mendelian idiopathic epilepsies.
Neurol Clin, 2009 Nov , 27 (1041-61).

227

Lee IC et al. Benign familial neonatal convulsions: novel mutation in a newborn.
Pediatr. Neurol., 2009 May , 40 (387-91).

231

Alaimo A et al. Calmodulin activation limits the rate of KCNQ2 K+ channel exit from the endoplasmic reticulum.
J. Biol. Chem., 2009 Jul 31 , 284 (20668-75).

232

Villalba-Galea CA et al. Coupling between the voltage-sensing and phosphatase domains of Ci-VSP.
J. Gen. Physiol., 2009 Jul , 134 (5-14).

234

Ishii A et al. A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions.
Brain Dev., 2009 Jan , 31 (27-33).

235

237

Brown DA et al. Neural KCNQ (Kv7) channels.
Br. J. Pharmacol., 2009 Apr , 156 (1185-95).

239

240

Mruk K et al. Discovery of a novel activator of KCNQ1-KCNE1 K channel complexes.
PLoS ONE, 2009 , 4 (e4236).

241

Wickenden AD et al. Kv7 channels as targets for the treatment of pain.
Curr. Pharm. Des., 2009 , 15 (1773-98).

242

Roura-Ferrer M et al. Functional implications of KCNE subunit expression for the Kv7.5 (KCNQ5) channel.
Cell. Physiol. Biochem., 2009 , 24 (325-34).

250

252

Bal M et al. Calmodulin binding to M-type K+ channels assayed by TIRF/FRET in living cells.
J. Physiol. (Lond.), 2008 May 1 , 586 (2307-20).

259

Shah MM et al. Functional significance of axonal Kv7 channels in hippocampal pyramidal neurons.
Proc. Natl. Acad. Sci. U.S.A., 2008 Jun 3 , 105 (7869-74).

263

Neubauer BA et al. KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes.
Neurology, 2008 Jul 15 , 71 (177-83).

264

Liu B et al. Phosphatidylinositol 4,5-bisphosphate hydrolysis mediates histamine-induced KCNQ/M current inhibition.
Am. J. Physiol., Cell Physiol., 2008 Jul , 295 (C81-91).

265

Schuetz F et al. Regulation of the voltage-gated K(+) channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1.
Am. J. Physiol., Cell Physiol., 2008 Jul , 295 (C73-80).

266

Fedorenko O et al. A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels.
Psychopharmacology (Berl.), 2008 Jul , 199 (47-54).

269

Xiong Q et al. Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers.
Proc. Natl. Acad. Sci. U.S.A., 2008 Feb 26 , 105 (3128-33).

270

Wladyka CL et al. The KCNQ/M-current modulates arterial baroreceptor function at the sensory terminal in rats.
J. Physiol. (Lond.), 2008 Feb 1 , 586 (795-802).

272

Tzingounis AV et al. Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents.
Proc. Natl. Acad. Sci. U.S.A., 2008 Dec 16 , 105 (19974-9).

276

Hansen HH et al. Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS.
J. Physiol. (Lond.), 2008 Apr 1 , 586 (1823-32).

277

Hernandez CC et al. Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications.
J. Physiol. (Lond.), 2008 Apr 1 , 586 (1811-21).

278

Maljevic S et al. Nervous system KV7 disorders: breakdown of a subthreshold brake.
J. Physiol. (Lond.), 2008 Apr 1 , 586 (1791-801).

279

Etxeberria A et al. Calmodulin regulates the trafficking of KCNQ2 potassium channels.
FASEB J., 2008 Apr , 22 (1135-43).

282

Elghezal H et al. Ring chromosome 20 syndrome without deletions of the subtelomeric and CHRNA4--KCNQ2 genes loci.
Eur J Med Genet, 2007 Nov-Dec , 50 (441-5).

285

Lucarini N et al. Genetic polymorphisms and idiopathic generalized epilepsies.
Pediatr. Neurol., 2007 Sep , 37 (157-64).

287

Wuttke TV et al. Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations.
Neurology, 2007 Nov 27 , 69 (2045-53).

291

Elmedyb P et al. Modulation of ERG channels by XE991.
Basic Clin. Pharmacol. Toxicol., 2007 May , 100 (316-22).

292

Punke MA et al. Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels.
Anesth. Analg., 2007 May , 104 (1256-64, tables of contents).

295

Steinlein OK et al. Benign familial neonatal convulsions: always benign?
Epilepsy Res., 2007 Mar , 73 (245-9).

298

Zhang ZS et al. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease.
Am. J. Physiol. Heart Circ. Physiol., 2007 Jan , 292 (H399-407).

300

Falace A et al. Inherited neuromyotonia: a clinical and genetic study of a family.
Neuromuscul. Disord., 2007 Jan , 17 (23-7).

303

Heron SE et al. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures.
J. Med. Genet., 2007 Dec , 44 (791-6).

305

308

Crozier RA et al. MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability.
J. Neurosci., 2007 Apr 18 , 27 (4492-6).

309

Wehling C et al. Self-assembly of the isolated KCNQ2 subunit interaction domain.
FEBS Lett., 2007 Apr 17 , 581 (1594-8).

310

Jensen HS et al. Inactivation as a new regulatory mechanism for neuronal Kv7 channels.
Biophys. J., 2007 Apr 15 , 92 (2747-56).

311

Borsotto M et al. PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder.
Pharmacogenomics J., 2007 Apr , 7 (123-32).

314

Zimprich F et al. Andreas Rett and benign familial neonatal convulsions revisited.
Neurology, 2006 Sep 12 , 67 (864-6).

317

Lawrence JJ et al. Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons.
J. Neurosci., 2006 Nov 22 , 26 (12325-38).

318

Bentzen BH et al. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
Neuropharmacology, 2006 Nov , 51 (1068-77).

320

Geiger J et al. Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain.
Neurosci. Lett., 2006 May 29 , 400 (101-4).

321

Schwarz JR et al. KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier.
J. Physiol. (Lond.), 2006 May 15 , 573 (17-34).

324

Seebohm G et al. Differential roles of S6 domain hinges in the gating of KCNQ potassium channels.
Biophys. J., 2006 Mar 15 , 90 (2235-44).

325

Kearney JA et al. Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2.
Hum. Mol. Genet., 2006 Mar 15 , 15 (1043-8).

336

Suh BC et al. Does diacylglycerol regulate KCNQ channels?
Pflugers Arch., 2006 Dec , 453 (293-301).

337

Gardiner M Molecular genetics of infantile nervous system channelopathies.
Early Hum. Dev., 2006 Dec , 82 (775-9).

338

Ferraro TN et al. Role of genetics in the diagnosis and treatment of epilepsy.
, 2006 Dec , 6 (1789-800).

340

Wladyka CL et al. KCNQ/M-currents contribute to the resting membrane potential in rat visceral sensory neurons.
J. Physiol. (Lond.), 2006 Aug 15 , 575 (175-89).

341

Li HY et al. [Clinical and mutational analysis of KCNQ3 gene in a Chinese family with benign familial neonatal convulsions]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006 Aug , 23 (374-7).

342

Schwake M et al. Structural determinants of M-type KCNQ (Kv7) K+ channel assembly.
J. Neurosci., 2006 Apr 5 , 26 (3757-66).

345

Strutz-Seebohm N et al. Functional coassembly of KCNQ4 with KCNE-beta- subunits in Xenopus oocytes.
Cell. Physiol. Biochem., 2006 , 18 (57-66).

346

Blackburn-Munro G et al. Retigabine: chemical synthesis to clinical application.
, 2005 Spring , 11 (1-20).

348

Shahidullah M et al. Expression of a calmodulin-binding KCNQ2 potassium channel fragment modulates neuronal M-current and membrane excitability.
Proc. Natl. Acad. Sci. U.S.A., 2005 Nov 8 , 102 (16454-9).

349

Penschuck S et al. Changes in KCNQ2 immunoreactivity in the amygdala in two rat models of temporal lobe epilepsy.
Brain Res. Mol. Brain Res., 2005 Nov 18 , 141 (66-73).

350

Nakajo K et al. Protein kinase C shifts the voltage dependence of KCNQ/M channels expressed in Xenopus oocytes.
J. Physiol. (Lond.), 2005 Nov 15 , 569 (59-74).

351

Schenzer A et al. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.
J. Neurosci., 2005 May 18 , 25 (5051-60).

353

Lan WZ et al. Electrophysiological and molecular identification of hepatocellular volume-activated K+ channels.
Biochim. Biophys. Acta, 2005 Mar 1 , 1668 (223-33).

354

Wang X et al. [Advances in the studies on the molecular and genetic aspects of epilepsy]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2005 Jun , 27 (388-93).

355

Wolff C et al. [3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction.
Eur. J. Pharmacol., 2005 Jul 25 , 518 (10-7).

356

Schmitt B et al. Neonatal seizures with tonic clonic sequences and poor developmental outcome.
Epilepsy Res., 2005 Jul , 65 (161-8).

357

Surti TS et al. A potassium channel, the M-channel, as a therapeutic target.
, 2005 Jul , 6 (704-11).

358

Pinto D et al. Gene symbol: KCNQ2. Disease: Benign neonatal familial convulsion.
Hum. Genet., 2005 Jul , 117 (300).

361

Devaux JJ et al. Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA.
J. Neurosci., 2005 Feb 9 , 25 (1470-80).

362

368

Wua YJ et al. Recent developments on KCNQ potassium channel openers.
Curr. Med. Chem., 2005 , 12 (453-60).

369

Liang G et al. An M-like potassium current in the guinea pig cochlea.
ORL J. Otorhinolaryngol. Relat. Spec., 2005 , 67 (75-82).

371

Gardiner M Genetics of idiopathic generalized epilepsies.
Epilepsia, 2005 , 46 Suppl 9 (15-20).

372

Burgess DL Neonatal epilepsy syndromes and GEFS+: mechanistic considerations.
Epilepsia, 2005 , 46 Suppl 10 (51-8).

375

376

Etxeberria A et al. Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation.
J. Neurosci., 2004 Oct 13 , 24 (9146-52).

379

Kelemen A et al. [Genetic background of epilepsies]
, 2004 May 20 , 57 (141-51).

381

387

Devaux JJ et al. KCNQ2 is a nodal K+ channel.
J. Neurosci., 2004 Feb 4 , 24 (1236-44).

388

Claes LR et al. De novo KCNQ2 mutations in patients with benign neonatal seizures.
Neurology, 2004 Dec 14 , 63 (2155-8).

389

Punke MA et al. Retigabine stimulates human KCNQ2/Q3 channels in the presence of bupivacaine.
Anesthesiology, 2004 Aug , 101 (430-8).

394

399

Grunnet M et al. KCNQ1 channels sense small changes in cell volume.
J. Physiol. (Lond.), 2003 Jun 1 , 549 (419-27).

400

402

Zhang ZH et al. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.
Brain Res. Mol. Brain Res., 2003 Jul 4 , 115 (29-38).

404

Gamper N et al. Calmodulin mediates Ca2+-dependent modulation of M-type K+ channels.
J. Gen. Physiol., 2003 Jul , 122 (17-31).

405

Seebohm G et al. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
Mol. Pharmacol., 2003 Jul , 64 (70-7).

406

Gamper N et al. Subunit-specific modulation of KCNQ potassium channels by Src tyrosine kinase.
J. Neurosci., 2003 Jan 1 , 23 (84-95).

409

Okada M et al. Age-dependent modulation of hippocampal excitability by KCNQ-channels.
Epilepsy Res., 2003 Feb , 53 (81-94).

412

Gribkoff VK The therapeutic potential of neuronal KCNQ channel modulators.
Expert Opin. Ther. Targets, 2003 Dec , 7 (737-48).

413

Li HY et al. [A novel mutation of KCNQ2 gene in a Chinese family with benign familial neonatal convulsions]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2003 Dec , 20 (482-5).

414

Passmore GM et al. KCNQ/M currents in sensory neurons: significance for pain therapy.
J. Neurosci., 2003 Aug 6 , 23 (7227-36).

417

Maljevic S et al. C-terminal interaction of KCNQ2 and KCNQ3 K+ channels.
J. Physiol. (Lond.), 2003 Apr 15 , 548 (353-60).

418

Cooper EC et al. M-channels: neurological diseases, neuromodulation, and drug development.
Arch. Neurol., 2003 Apr , 60 (496-500).

422

Wen H et al. Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels.
J. Neurosci., 2002 Sep 15 , 22 (7991-8001).

423

424

Shah MM et al. Molecular correlates of the M-current in cultured rat hippocampal neurons.
J. Physiol. (Lond.), 2002 Oct 1 , 544 (29-37).

426

Grunnet M et al. KCNE4 is an inhibitory subunit to the KCNQ1 channel.
J. Physiol. (Lond.), 2002 Jul 1 , 542 (119-30).

427

431

Wickenden AD Potassium channels as anti-epileptic drug targets.
Neuropharmacology, 2002 Dec , 43 (1055-60).

433

Guo J et al. Histamine inhibits KCNQ2/KCNQ3 channel current via recombinant histamine H(1) receptors.
Neurosci. Lett., 2002 Aug 16 , 328 (285-8).

435

Steinlein OK Channelopathies can cause epilepsy in man.
, 2002 , 6 Suppl A (27-34).

436

Kaneko S et al. Genetic identifiers of epilepsy.
Epilepsia, 2002 , 43 Suppl 9 (16-20).

437

Okada M et al. Impaired M-current and neuronal excitability.
Epilepsia, 2002 , 43 Suppl 9 (36-8).

439

Serrano-Castro PJ et al. [Ring chromosome 20: an epileptic channel disorder?]
Rev Neurol, 2001 Feb 1-15 , 32 (237-41).

440

Steinlein OK Genes and mutations in idiopathic epilepsy.
Am. J. Med. Genet., 2001 Summer , 106 (139-45).

441

Lerche H et al. Ion channels and epilepsy.
Am. J. Med. Genet., 2001 Summer , 106 (146-59).

442

Dedek K et al. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel.
Proc. Natl. Acad. Sci. U.S.A., 2001 Oct 9 , 98 (12272-7).

443

Meissner P et al. Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells.
Biotechnol. Bioeng., 2001 Oct 20 , 75 (197-203).

445

Moulard B et al. Ion channel variation causes epilepsies.
Brain Res. Brain Res. Rev., 2001 Oct , 36 (275-84).

446

Korolkova YV et al. An ERG channel inhibitor from the scorpion Buthus eupeus.
J. Biol. Chem., 2001 Mar 30 , 276 (9868-76).

448

Schrøder RL et al. KCNQ4 channel activation by BMS-204352 and retigabine.
Neuropharmacology, 2001 Jun , 40 (888-98).

450

Selyanko AA et al. Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells.
J. Physiol. (Lond.), 2001 Jul 1 , 534 (15-24).

453

Xiao JF et al. Cloning and mutation analysis of the human potassium channel KCNQ2 gene promoter.
Neuroreport, 2001 Dec 4 , 12 (3733-9).

455

Yin H et al. Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein.
Cytokine, 2001 Aug 7 , 15 (122-37).

458

Robbins J KCNQ potassium channels: physiology, pathophysiology, and pharmacology.
Pharmacol. Ther., 2001 Apr , 90 (1-19).

460

Jow F et al. Cloning and functional expression of rKCNQ2 K(+) channel from rat brain.
Brain Res. Mol. Brain Res., 2000 Sep 15 , 80 (269-78).

461

Tinel N et al. M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2 subunit.
FEBS Lett., 2000 Sep 1 , 480 (137-41).

463

Wickenden AD et al. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.
Mol. Pharmacol., 2000 Sep , 58 (591-600).

467

Gardiner RM Impact of our understanding of the genetic aetiology of epilepsy.
J. Neurol., 2000 May , 247 (327-34).

468

Barrantes FJ et al. The neuronal nicotinic acetylcholine receptor in some hereditary epilepsies.
Neurochem. Res., 2000 May , 25 (583-90).

471

Huertas D et al. Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells.
Hum. Mol. Genet., 2000 Mar 1 , 9 (617-29).

472

Kananura C et al. The new voltage gated potassium channel KCNQ5 and neonatal convulsions.
Neuroreport, 2000 Jun 26 , 11 (2063-7).

475

Watanabe H et al. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability.
J. Neurochem., 2000 Jul , 75 (28-33).

476

478

Hadley JK et al. Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels.
Br. J. Pharmacol., 2000 Feb , 129 (413-5).

479

480

Miraglia del Giudice E et al. Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor.
Eur. J. Hum. Genet., 2000 Dec , 8 (994-7).

482

Schroeder BC et al. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents.
J. Biol. Chem., 2000 Aug 4 , 275 (24089-95).

483

Main MJ et al. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
Mol. Pharmacol., 2000 Aug , 58 (253-62).

485

Cooper EC et al. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy.
Proc. Natl. Acad. Sci. U.S.A., 2000 Apr 25 , 97 (4914-9).

486

Tolmachova T et al. Analysis of a YAC with human telomeres and oriP from epstein-barr virus in yeast and 293 cells.
Nucleic Acids Res., 1999 Sep 15 , 27 (3736-44).

488

Lerche H et al. A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions.
Ann. Neurol., 1999 Sep , 46 (305-12).

489

Rho JM et al. Developmental seizure susceptibility of kv1.1 potassium channel knockout mice.
Dev. Neurosci., 1999 Nov , 21 (320-7).

490

McCormack T et al. Chromosomal mapping of the potassium channel genes Kcnq2 and Kcnq3 in mouse.
Genomics, 1999 Mar 15 , 56 (360-1).

492

Meves H et al. Separation of M-like current and ERG current in NG108-15 cells.
Br. J. Pharmacol., 1999 Jul , 127 (1213-23).

493

Hirsch E et al. [Benign familial neonatal convulsions: a model of idiopathic epilepsy]
Rev. Neurol. (Paris), 1999 Jul , 155 (463-7).

494

Steinlein OK et al. The voltage gated potassium channel KCNQ2 and idiopathic generalized epilepsy.
Neuroreport, 1999 Apr 26 , 10 (1163-6).

495

Steinlein OK Idiopathic epilepsies with a monogenic mode of inheritance.
Epilepsia, 1999 , 40 Suppl 3 (9-11).

496

Leppert MF et al. Susceptibility genes in human epilepsy.
, 1999 , 19 (397-405).

498

Steinlein OK et al. KCNQ2, the first gene found to be mutated in human generalized idiopathic epilepsy.
Pathol. Biol., 1998 Nov , 46 (683-4).

500

Biervert C et al. A potassium channel mutation in neonatal human epilepsy.
Science, 1998 Jan 16 , 279 (403-6).

503

504